B. Mary E. von Blomberg

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2

Bob W. van Oosten, Frederik Barkhof, L. Truyen et al. · Neurology · 1996 · 733 citations

Life Sciences, Immunology, Neurology +17

Underlying disorders associated with severe early-onset preeclampsia

G.A. Dekker, Johanna I.P. de Vries, P.M. Doelitzsch et al. · American Journal of Obstetrics and Gynecology · 1995 · 524 citations

Medicine, Maternal Health, Obstetrics +12

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

Giuseppe Giaccone, Cornelis J. A. Punt, Rita Ruijter et al. · PubMed · 2002 · 507 citations

Medicine, Oncology, Pharmacology +17

Secretion of Tumour Necrosis Factor α and Lymphotoxin α in Relation to Polymorphisms in the TNF Genes and HLA‐DR Alleles. Relevance for Inflammatory Bowel Disease

J. Bart A. Crusius, M. Oudkerk Pool, J. J. Kolkman et al. · Scandinavian Journal of Immunology · 1996 · 378 citations

Life Sciences, Genetics, Immunology +13

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons JM van den Eertwegh, Jurjen Versluis, H. Pieter van den Berg et al. · The Lancet Oncology · 2012 · 357 citations

Medicine, Immunology, Oncology +16